UnknownEarly Phase 1

Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery

Pakistan60 participantsStarted 2023-12-30

Plain-language summary

Comparison of I/V nalbuphine versus I/V xylocain in attanuation of pressor response during intubation and laryngeoscopy in patients undergoing for thyroid surgery,selection of better supressor agent minimises the drug repated side effects like hypertention tachycardia but also helps in heamodynamically stability at induction.

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * middle age(18\_40) * Asa 1 and 2 * Non hypertensive * Thyroid patients * patient who gives consent Exclusion Criteria: * hypertensive * Asa 3 and 4 * Patient refusal

What they're measuring

Reduce stress response during intubation and hemodynamic stabilty

Timeframe: 10 minutes

Achieve hemodynamic stabilty and smooth intubation

Timeframe: 10 minutes

Trial details

NCT IDNCT05298761

SponsorSheikh Zayed Medical College

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2024-03-01

Contact for this trial

Dr.amna Sarwar, Fcps

03218337129 Dr.amnasabir@gmail.com

View on ClinicalTrials.gov More Hemodynamic Stability trials